Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Tspan8-β-catenin positive feedback loop promotes melanoma invasion.

El Kharbili M, Agaësse G, Barbollat-Boutrand L, Pommier RM, de la Fouchardière A, Larue L, Caramel J, Puisieux A, Berthier-Vergnes O, Masse I.

Oncogene. 2019 May;38(20):3781-3793. doi: 10.1038/s41388-019-0691-z. Epub 2019 Jan 24.

PMID:
30679790
2.

A large-scale RNAi screen identifies LCMR1 as a critical regulator of Tspan8-mediated melanoma invasion.

Agaësse G, Barbollat-Boutrand L, Sulpice E, Bhajun R, El Kharbili M, Berthier-Vergnes O, Degoul F, de la Fouchardière A, Berger E, Voeltzel T, Lamartine J, Gidrol X, Masse I.

Oncogene. 2017 Aug 31;36(35):5084. doi: 10.1038/onc.2017.195. Epub 2017 Jun 19.

PMID:
28628117
3.

Tetraspanin 8 (TSPAN 8) as a potential target for radio-immunotherapy of colorectal cancer.

Maisonial-Besset A, Witkowski T, Navarro-Teulon I, Berthier-Vergnes O, Fois G, Zhu Y, Besse S, Bawa O, Briat A, Quintana M, Pichard A, Bonnet M, Rubinstein E, Pouget JP, Opolon P, Maigne L, Miot-Noirault E, Chezal JM, Boucheix C, Degoul F.

Oncotarget. 2017 Mar 28;8(13):22034-22047. doi: 10.18632/oncotarget.15787.

4.

p53 targets TSPAN8 to prevent invasion in melanoma cells.

Agaësse G, Barbollat-Boutrand L, El Kharbili M, Berthier-Vergnes O, Masse I.

Oncogenesis. 2017 Apr 3;6(4):e309. doi: 10.1038/oncsis.2017.11.

5.

Tetraspanin 8 is a novel regulator of ILK-driven β1 integrin adhesion and signaling in invasive melanoma cells.

El Kharbili M, Robert C, Witkowski T, Danty-Berger E, Barbollat-Boutrand L, Masse I, Gadot N, de la Fouchardière A, McDonald PC, Dedhar S, Le Naour F, Degoul F, Berthier-Vergnes O.

Oncotarget. 2017 Mar 7;8(10):17140-17155. doi: 10.18632/oncotarget.15084.

6.

A large-scale RNAi screen identifies LCMR1 as a critical regulator of Tspan8-mediated melanoma invasion.

Agaësse G, Barbollat-Boutrand L, Sulpice E, Bhajun R, El Kharbili M, Berthier-Vergnes O, Degoul F, de la Fouchardière A, Berger E, Voeltzel T, Lamartine J, Gidrol X, Masse I.

Oncogene. 2017 Jan 26;36(4):446-457. doi: 10.1038/onc.2016.219. Epub 2016 Jul 4. Erratum in: Oncogene. 2017 Jun 19;:.

PMID:
27375018
7.

MicroRNA-23b-3p regulates human keratinocyte differentiation through repression of TGIF1 and activation of the TGF-ß-SMAD2 signalling pathway.

Barbollat-Boutrand L, Joly-Tonetti N, Dos Santos M, Metral E, Boher A, Masse I, Berthier-Vergnes O, Bertolino P, Damour O, Lamartine J.

Exp Dermatol. 2017 Jan;26(1):51-57. doi: 10.1111/exd.13119.

PMID:
27306475
8.

[Tetraspanins in cutaneous physiopathology].

Masse I, Agaësse G, Berthier-Vergnes O.

Med Sci (Paris). 2016 Mar;32(3):267-73. doi: 10.1051/medsci/20163203011. Epub 2016 Mar 23. Review. French.

9.

Synthesis and biological evaluation of thiophene and benzo[b]thiophene analogs of combretastatin A-4 and isocombretastatin A-4: A comparison between the linkage positions of the 3,4,5-trimethoxystyrene unit.

Do CV, Faouzi A, Barette C, Farce A, Fauvarque MO, Colomb E, Catry L, Berthier-Vergnes O, Haftek M, Barret R, Lomberget T.

Bioorg Med Chem Lett. 2016 Jan 1;26(1):174-80. doi: 10.1016/j.bmcl.2015.11.010. Epub 2015 Nov 10.

PMID:
26602281
10.

GATA3 inhibits proliferation and induces expression of both early and late differentiation markers in keratinocytes of the human epidermis.

Masse I, Barbollat-Boutrand L, Kharbili ME, Berthier-Vergnes O, Aubert D, Lamartine J.

Arch Dermatol Res. 2014 Mar;306(2):201-8. doi: 10.1007/s00403-013-1435-5. Epub 2013 Dec 18.

PMID:
24346062
11.

Functional interplay between p63 and p53 controls RUNX1 function in the transition from proliferation to differentiation in human keratinocytes.

Masse I, Barbollat-Boutrand L, Molina M, Berthier-Vergnes O, Joly-Tonetti N, Martin MT, Caron de Fromentel C, Kanitakis J, Lamartine J.

Cell Death Dis. 2012 Jun 7;3:e318. doi: 10.1038/cddis.2012.62.

12.

Gene expression profiles of human melanoma cells with different invasive potential reveal TSPAN8 as a novel mediator of invasion.

Berthier-Vergnes O, El Kharbili M, de la Fouchardière A, Pointecouteau T, Verrando P, Wierinckx A, Lachuer J, Le Naour F, Lamartine J.

Br J Cancer. 2011 Jan 4;104(1):155-65. doi: 10.1038/sj.bjc.6605994. Epub 2010 Nov 16.

13.

GATA3 is a master regulator of the transcriptional response to low-dose ionizing radiation in human keratinocytes.

Bonin F, Molina M, Malet C, Ginestet C, Berthier-Vergnes O, Martin MT, Lamartine J.

BMC Genomics. 2009 Sep 7;10:417. doi: 10.1186/1471-2164-10-417.

14.

Poly(I:C)-Treated human langerhans cells promote the differentiation of CD4+ T cells producing IFN-gamma and IL-10.

Furio L, Billard H, Valladeau J, Péguet-Navarro J, Berthier-Vergnes O.

J Invest Dermatol. 2009 Aug;129(8):1963-71. doi: 10.1038/jid.2009.21. Epub 2009 Feb 26.

15.

Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria.

Flacher V, Bouschbacher M, Verronèse E, Massacrier C, Sisirak V, Berthier-Vergnes O, de Saint-Vis B, Caux C, Dezutter-Dambuyant C, Lebecque S, Valladeau J.

J Immunol. 2006 Dec 1;177(11):7959-67.

16.

Melanoma-derived gangliosides impair migratory and antigen-presenting function of human epidermal Langerhans cells and induce their apoptosis.

Bennaceur K, Popa I, Portoukalian J, Berthier-Vergnes O, Péguet-Navarro J.

Int Immunol. 2006 Jun;18(6):879-86. Epub 2006 May 4.

PMID:
16675488
17.

UVA radiation impairs phenotypic and functional maturation of human dermal dendritic cells.

Furio L, Berthier-Vergnes O, Ducarre B, Schmitt D, Peguet-Navarro J.

J Invest Dermatol. 2005 Nov;125(5):1032-8.

18.

TNF-alpha enhances phenotypic and functional maturation of human epidermal Langerhans cells and induces IL-12 p40 and IP-10/CXCL-10 production.

Berthier-Vergnes O, Bermond F, Flacher V, Massacrier C, Schmitt D, Péguet-Navarro J.

FEBS Lett. 2005 Jul 4;579(17):3660-8.

19.

Comparative expression of vascular endothelial growth factor family members, VEGF-B, -C and -D, by normal human keratinocytes and fibroblasts.

Trompezinski S, Berthier-Vergnes O, Denis A, Schmitt D, Viac J.

Exp Dermatol. 2004 Feb;13(2):98-105.

PMID:
15009103
20.

Human melanoma cells inhibit the earliest differentiation steps of human Langerhans cell precursors but failed to affect the functional maturation of epidermal Langerhans cells.

Berthier-Vergnes O, Gaucherand M, Péguet-Navarro J, Plouet J, Pageaux JF, Schmitt D, Staquet MJ.

Br J Cancer. 2001 Dec 14;85(12):1944-51.

21.

Cumulative influence of matrix metalloproteinase-1 and -2 in the migration of melanoma cells within three-dimensional type I collagen lattices.

Ntayi C, Lorimier S, Berthier-Vergnes O, Hornebeck W, Bernard P.

Exp Cell Res. 2001 Oct 15;270(1):110-8.

PMID:
11597133
23.

Penetration of human metastatic melanoma cells through an authentic dermal-epidermal junction is associated with dissolution of native collagen types IV and VII.

Bechetoille N, Haftek M, Staquet MJ, Cochran AJ, Schmitt D, Berthier-Vergnes O.

Melanoma Res. 2000 Oct;10(5):427-34.

PMID:
11095403
24.

Cytoplasmic accumulation of peanut agglutinin-binding glycoconjugates in the cells of primary melanoma correlates with clinical outcome.

Cochran AJ, Wen DR, Berthier-Vergnes O, Bailly C, Doré JF, Bérard F, Moulin G, Thomas L.

Hum Pathol. 1999 May;30(5):556-61.

PMID:
10333227
25.

Human epidermal Langerhans cells express the mannose-fucose binding receptor.

Condaminet B, Péguet-Navarro J, Stahl PD, Dalbiez-Gauthier C, Schmitt D, Berthier-Vergnes O.

Eur J Immunol. 1998 Nov;28(11):3541-51.

26.

Variable expression of Mn SOD in three different human melanoma cell lines.

Varachaud A, Berthier-Vergnes O, Rigaud M, Schmitt D, Bernard P.

Eur J Dermatol. 1998 Mar;8(2):90-4.

PMID:
9649709
27.

Unusual lactam formation occurring in the synthesis of a biotinylated T-antigen-serine derivative.

Bay S, Berthier-Vergnes O, Biberovic V, Cantacuzène D.

Carbohydr Res. 1997 Aug 25;303(1):25-31.

PMID:
9345750
28.

Synthesis of alpha- and beta-biotinylated T-antigen.

Bay S, Berthier-Vergnes O, Cantacuzene D.

Carbohydr Res. 1997 Mar 5;298(3):153-61.

PMID:
9090812
29.

Thrombospondin modulates melanoma--platelet interactions and melanoma tumour cell growth in vivo.

Boukerche H, Berthier-Vergnes O, Tabone E, Bailly M, Doré JF, McGregor JL.

Br J Cancer. 1995 Jul;72(1):108-16.

30.
31.

Selective expression of PNA-binding glycoconjugates by invasive human melanomas: a new marker of metastatic potential.

Doré JF, Berthier-Vergnes O, Zebda N, Bailly M, Thomas L, Bailly C, Cochran AJ.

Pigment Cell Res. 1994 Dec;7(6):461-4. Review.

PMID:
7761355
32.

Human melanoma cell lines differ in their capacity to release ADP and aggregate platelets.

Boukerche H, Berthier-Vergnes O, Penin F, Tabone E, Lizard G, Bailly M, McGregor JL.

Br J Haematol. 1994 Aug;87(4):763-72.

PMID:
7527241
33.

Expression of the galactose binding protein Mac-2 by human melanoma cell-lines.

Mey A, Berthier-Vergnes O, Apoil PA, Doré JF, Revillard JP.

Cancer Lett. 1994 Jun 30;81(2):155-63.

PMID:
8012932
34.

Induction of IgG antibodies directed to a M(r) 31,000 melanoma antigen in patients immunized with vaccinia virus melanoma oncolysates.

Berthier-Vergnes O, Portoukalian J, Lefthériotis E, Doré JF.

Cancer Res. 1994 May 1;54(9):2433-9.

35.

Two human melanoma cell-line variants with enhanced in vivo tumor growth and metastatic capacity do not express the beta 3 integrin subunit.

Boukerche H, Benchaibi M, Berthier-Vergnes O, Lizard G, Bailly M, Bailly M, McGregor JL.

Eur J Biochem. 1994 Mar 1;220(2):485-91.

36.

Expression of PNA-binding sites on specific glycoproteins by human melanoma cells is associated with a high metastatic potential.

Zebda N, Bailly M, Brown S, Doré JF, Berthier-Vergnes O.

J Cell Biochem. 1994 Feb;54(2):161-73.

PMID:
8175891
37.

The role of the alpha v beta 3 integrin (vitronectin receptor) in platelet-melanoma interaction and metastasis.

Boukerche H, McGregor B, Berthier-Vergnes O, McGregor J.

Nouv Rev Fr Hematol. 1993 Jun;35(3):267-8. No abstract available.

PMID:
7687772
38.

Expression of peanut agglutinin-binding glycoconjugates in primary melanomas with high risk of metastases.

Berthier-Vergnes O, Zebda N, Bailly M, Bailly C, Doré JF, Thomas L, Cochran AJ.

Lancet. 1993 May 15;341(8855):1292. No abstract available.

PMID:
8098445
39.

Expression of cell surface sialic acid and galactose by normal adult human melanocytes in culture.

Berthier-Vergnes O, Berrux V, Réano A, Doré JF.

Pigment Cell Res. 1990 Mar-Apr;3(2):55-60.

PMID:
2385567
40.

[Response in patients with melanoma to immunization using melanoma oncolysates of vaccine virus].

Doré JF, Portoukalian J, Berthier-Vergnes O, Jacubovich R, Genève J, Bailly M, Lefthériotis E, Weissbrod A, Mayer M.

Bull Cancer. 1990;77(9):881-91. French.

PMID:
2224160
41.

A monoclonal antibody (LYP18) directed against the blood platelet glycoprotein IIb/IIIa complex inhibits human melanoma growth in vivo.

Boukerche H, Berthier-Vergnes O, Bailly M, Doré JF, Leung LL, McGregor JL.

Blood. 1989 Aug 15;74(3):909-12.

PMID:
2752160
42.

Platelet-melanoma cell interaction is mediated by the glycoprotein IIb-IIIa complex.

Boukerche H, Berthier-Vergnes O, Tabone E, Doré JF, Leung LL, McGregor JL.

Blood. 1989 Aug 1;74(2):658-63.

PMID:
2752140
43.

Lectin binding glycoproteins in human melanoma cell lines with high or low tumorigenicity.

Berthier-Vergnes O, Réano A, Doré JF.

Int J Cancer. 1986 May 15;37(5):747-51.

PMID:
3754539
44.

Surface distribution of wheat germ agglutinin binding sites of human melanoma cell lines with low and high tumorigenicity.

Berthier-Vergnes O, Deugnier MA, Reano A, Doré JF.

Biochem Int. 1985 Nov;11(5):669-76.

PMID:
4091844
45.

Expression of cell surface glycoproteins in human melanoma cell lines with different tumorigenic properties.

Berthier-Vergnes O, Portoukalian J, Doré JF.

Int J Cancer. 1985 Oct 15;36(4):461-6.

PMID:
4044055
46.

Supplemental Content

Loading ...
Support Center